Ann Arbor, MI, United States of America

Jiuling Yang

USPTO Granted Patents = 3 

 

Average Co-Inventor Count = 7.8

ph-index = 1


Location History:

  • Ann Arbor, MI (US) (2020 - 2021)
  • Ypsilanti, MI (US) (2021)

Company Filing History:


Years Active: 2020-2021

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Inventor Jiuling Yang

Introduction: Jiuling Yang, based in Ann Arbor, Michigan, is a notable inventor with a focus on groundbreaking developments in cancer treatment. With a total of three patents, his work significantly impacts the pharmaceutical field, particularly in the creation of compounds designed to target MDM2 proteins.

Latest Patents: Jiuling Yang's latest innovations include advanced MDM2 protein degraders. The first patent describes compounds represented by Formula I-A: A-L-BI-A, along with their pharmaceutically acceptable salts, hydrates, and solvates. These compounds are designed for treating conditions responsive to MDM2 protein degradation, specifically targeting cancer. Furthermore, his second patent on small molecule MDM2 protein degraders elaborates on compounds illustrated in Formula I, aiming for similar therapeutic applications. The use of these compounds demonstrates Yang’s commitment to developing effective cancer treatments.

Career Highlights: Currently, Jiuling Yang holds a significant position at the University of Michigan, where he continues to innovate and contribute to the field of medicinal chemistry. His work not only focuses on the discovery of new therapeutic agents but also emphasizes the efficiency of using small molecules to combat complex diseases like cancer.

Collaborations: Throughout his career, Yang has collaborated with esteemed colleagues such as Shaomeng Wang and Yangbing Li. These collaborations highlight the importance of teamwork in research and innovation, leading to breakthroughs that can have a meaningful impact on patient care.

Conclusion: Jiuling Yang’s contributions as an inventor are valuable assets to the medical and research communities. His research and discoveries related to MDM2 protein degraders pave the way for advancements in cancer treatment, showcasing the crucial role of innovation in addressing significant health challenges. Through his ongoing work, Yang exemplifies the spirit of invention that drives progress in the pharmaceutical industry.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…